-
Real-time NAT enables remote COVID-19 testing
Mar 30, 2020, 00:09 AM by Michael CroftSYDNEY, AUSTRALIA - Mar 30, 2020 - Real-time NAT enables remote COVID-19 testingSydney, Australia, 30 March 2020: An Australian biotech has helped develop a mobile COVID-19 testing system that delivers highly accurate results within an hour, potentially slowing the spread of the virusFull story -
Microway Announces Delivery of Its Largest 2nd Gen AMD EPYC™ Processor-powered Cluster to Date
Mar 27, 2020, 14:36 PM by Michael CroftPLYMOUTH, MA, UNITED STATES - Mar 27, 2020 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces it has delivered a full-scale 2nd Gen AMD EPYC processor-powered cluster to a major insurance companyFull story -
New Virtual Reality Tool Simplifies Structure-Based Drug Design
Mar 27, 2020, 11:40 AM by Michael CroftFull storyBio-IT World | A virtual reality (VR) platform developed by researchers at the University of Bristol is allowing chemists, computational scientists and structural biologists to collaboratively design molecules like engineers create airplane components.
-
DermTech Announces Response to COVID-19
Mar 26, 2020, 12:45 PM by Michael CroftNEW YORK, NY, UNITED STATES - Mar 25, 2020 - DermTech, Inc. (NASDAQ: DMTK) (DermTech), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today released the following letter from its CEO John Dobak, MFull story -
To Aid with COVID-19 Efforts, PhenoTips Offers Free Cloud-Hosted Genomics Software
Mar 24, 2020, 16:00 PM by Michael CroftTORONTO, ON, CANADA - Mar 24, 2020 - PhenoTips, a leading provider of precision medicine software, has announced their efforts to support genomic research during the COVID-19 pandemic in a blog post released on their websiteFull story -
Building A File System To Keep Up With Genomics England’s Five Million Genomes Project
Mar 24, 2020, 12:50 PM by Michael CroftFull storyBio-IT World When David Ardley took over the platforms function at Genomics England, he inherited “quite a challenging storage environment,” he told Bio-IT World. Genomics England expected to host over 140 petabytes of genomic data by 2023, and the current storage couldn't keep up. The group chose WekaIO to build the new storage environment.
-
WCG Launches Program to Provide Clinical Research Professionals with Timely Information During the COVID-19 Pandemic
Mar 23, 2020, 15:53 PM by Michael CroftPRINCETON, NJ - Mar 23, 2020 - WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, this week launched "The WCG Insights Program: Supporting best practices in a global pandemicxFull story -
Rho Experts Share Best Practices for Managing Risks in Clinical Trials
Mar 23, 2020, 13:55 PM by Michael CroftDURHAM - Mar 23, 2020 - Rho Experts Share Best Practices for Managing Risks in Clinical TrialsFree webinar offers insight into recent Good Clinical Practice (GCP) revisions on sponsor responsibilities for risk management WHAT: Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will outline and provide tips on the UFull story -
Global Flow Cytometry Market to Register Impressive Growth, Demand Upheld by Cancer and Stem Cell Research, Says Fact.MR
Mar 23, 2020, 10:31 AM by Michael CroftDUBLIN 2, IRELAND - Mar 23, 2020 - Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interactionFull story -
Creative Diagnostics Now Launches New Plant Pathogens Antibodies for Research Use
Mar 23, 2020, 03:44 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Mar 23, 2020 - As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches high-quality plant pathogens antibodies that are suitable for use in ELISA or related immunoassays and can be ordered in bulk quantityFull story -
Adaptive Biotechnologies, Microsoft Launch Immune Response Trial For COVID-19
Mar 20, 2020, 16:25 PM by Michael CroftBio-IT World Brief | Adaptive Biotechnologies and Microsoft today announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19 in a clinical trial to launch in April.Full story -
BioTeam, NVIDIA, Globus, And More Offer Free Tools To Support Coronavirus Research
Mar 20, 2020, 09:35 AM by Michael CroftBio-IT World | Groups across the Bio-IT World community are offering their services and tools for free to teams working on coronavirus diagnostics and treatments. Offerings from BioTeam, Globus, NVIDIA, the Broad Institute, Rescale, Google Cloud, and Microsoft Azure all aim to speed work done on diagnostics and treatment.Full story -
Creative Proteomics Released Choline and Choline Metabolites Analysis Service for Research Use
Mar 19, 2020, 22:52 PM by Michael CroftSHIRLEY, NY - Mar 20, 2020 - March 20, 2020, Creative Proteomics has released choline and choline metabolites analysis service to assist researchers in their biotechnological projectsFull story -
KONZA to Deliver Actionable Patient Information to Participating Provider Organizations with Diameter Health Technology
Mar 19, 2020, 11:26 AM by Michael CroftFARMINGTON, CT, UNITED STATES - Mar 19, 2020 - Diameter Health, developer of the leading platform for clinical data normalization and enhancement, today announced that KONZA, IncFull story -
Matthew Trunnell On Data, Silos, COVID-19, And Advice To Himself 15 Years Ago
Mar 19, 2020, 10:15 AM by Michael CroftFull storyBio-IT World TRENDS FROM THE TRENCHES—Stan Gloss and Matthew Trunnell discuss how their views of data have changed over the past two decades, what technologies provided tipping points, where the next leaps will happen, and what we may have done differently with the benefit of hindsight. And, of course, a little bit about coronavirus.
-
Albumedix Announces CBER FDA Drug Master File Acceptance for Recombumin® Elite and Appointment of Director of Regulatory Affairs
Mar 19, 2020, 09:01 AM by Michael CroftNOTTINGHAM, ENGLAND - Mar 19, 2020 - Albumedix Ltd. (Albumedix), the world leader in recombinant human albumin (rHA), announced today that the Center for Biologics Evaluation and Research (CBER), one of six main centers for the UFull story -
Robust, Powerful Compound Screening Platform Enhanced for Drug Screening Research
Mar 19, 2020, 04:09 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Mar 19, 2020 - The New York-based chemical supplier BOC Sciences, also one of the active players in early drug discovery, recently announces to enhance its one-stop compound screening platform, which is efficient, economical and systematic, aiming to help scientists fulfill their screening needs arising from drug R&D projectsFull story -
ATCC Partners with Global Scientific Community to Respond to the Coronavirus Pandemic
Mar 18, 2020, 13:54 PM by Michael CroftSAN FRANCISCO BAY AREA, CA, US - Mar 18, 2020 - Manassas, VA - March 18, 2020 - ATCC, the world's premier biological materials management and standards organization, today announced it is expanding its support for the UFull story -
CluePoints´ Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations
Mar 18, 2020, 09:40 AM by Michael CroftKING OF PRUSSIA, PA, US - Mar 18, 2020 - CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreakFull story -
COVID-19 DETECTION IN UNDER 20 MINS – ICENI DIAGNOSTICS OFFERS NEW APPROACH
Mar 18, 2020, 07:20 AM by Michael CroftNORWICH, UK, UNITED KINGDOM - Mar 18, 2020 - The emergence of COVID-19 has exposed a frailty in our ability to rapidly detect and screen new infectious diseasesFull story